Publications by authors named "Gabriel E Arias-Berrios"
Article Synopsis
- This study investigates how often psoriasis patients stop their biologic therapy and looks at the demographics and health characteristics of these patients.
- A total of 77 psoriasis patients who had discontinued biologic therapy at least once were analyzed, revealing that common comorbidities included hypertension and diabetes, while adalimumab and ustekinumab were the most used biologics.
- The main reason for stopping therapy was lack of effectiveness, with insurance coverage also affecting the discontinuation of certain biologics; findings showed no significant links between therapy discontinuation and patient demographics.
Objective: To describe the patient population with mycosis fungoides (MF) in Puerto Rico in terms of demographics, disease course, and management.
Methods: We performed a retrospective chart review of patients with MF who were being followed at the University of Puerto Rico dermatology clinics from 1999 through 2016. Collected data included demographics, age at diagnosis, stage at diagnosis, follow-up time, treatment, and stage at the time of the study.